INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
INDUCE-3：一项随机 II/III 期研究，评估一线 Feladilimab 联合 Pembrolizumab 治疗复发/转移性头颈部鳞状细胞癌患者的疗效
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1197
Rischin, Danny; Hansen, Aaron R; Cohen, Ezra E W; Tahara, Makoto; Harrington, Kevin J; Haddad, Robert I; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J; Washburn, Michael L; Phillips-Jones, Amy; Russell, John; Roy-Ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe
